These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 18800258)
1. Influence of formulation and preparation process on ambroxol hydrochloride dry powder inhalation characteristics and aerosolization properties. Ren Y; Yu C; Meng K; Tang X Drug Dev Ind Pharm; 2008 Sep; 34(9):984-91. PubMed ID: 18800258 [TBL] [Abstract][Full Text] [Related]
2. Effects of formulation and operating variables on zanamivir dry powder inhalation characteristics and aerosolization performance. Yang Y; Yang Z; Ren Y; Mei X Drug Deliv; 2014 Sep; 21(6):480-6. PubMed ID: 24491208 [TBL] [Abstract][Full Text] [Related]
3. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method. You Y; Zhao M; Liu G; Tang X J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186 [TBL] [Abstract][Full Text] [Related]
4. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. Bosquillon C; Lombry C; Préat V; Vanbever R J Control Release; 2001 Feb; 70(3):329-39. PubMed ID: 11182203 [TBL] [Abstract][Full Text] [Related]
5. The influence of formulation components on the aerosolisation properties of spray-dried powders. Rabbani NR; Seville PC J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334 [TBL] [Abstract][Full Text] [Related]
6. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders. Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252 [TBL] [Abstract][Full Text] [Related]
7. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients. Minne A; Boireau H; Horta MJ; Vanbever R Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052 [TBL] [Abstract][Full Text] [Related]
8. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride. Karimi K; Katona G; Csóka I; Ambrus R J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047 [TBL] [Abstract][Full Text] [Related]
9. Baicalin/ambroxol hydrochloride combined dry powder inhalation formulation targeting lung delivery for treatment of idiopathic pulmonary fibrosis: Fabrication, characterization, pharmacokinetics, and pharmacodynamics. Qi D; Jia B; Peng H; He J; Pi J; Guo P; Zhang Y; Deng X; Li J; Liu Z Eur J Pharm Biopharm; 2023 Jul; 188():243-253. PubMed ID: 37224929 [TBL] [Abstract][Full Text] [Related]
10. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation. Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a new inhalable thymopentin formulation. Wang L; Zhang Y; Tang X Int J Pharm; 2009 Jun; 375(1-2):1-7. PubMed ID: 19443146 [TBL] [Abstract][Full Text] [Related]
12. Optimization and characterization of dry powder of fanhuncaoin for inhalation based on selection of excipients. Yang XB; Wang XB; Pan WS; Xi RG; Wang YN; Liu D; Shi Y; Jiang S Chem Pharm Bull (Tokyo); 2011; 59(8):929-37. PubMed ID: 21804235 [TBL] [Abstract][Full Text] [Related]
13. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease. Adi H; Young PM; Chan HK; Agus H; Traini D Eur J Pharm Sci; 2010 Jun; 40(3):239-47. PubMed ID: 20371286 [TBL] [Abstract][Full Text] [Related]
14. Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols. Chew NY; Chan HK Pharm Res; 1999 Jul; 16(7):1098-103. PubMed ID: 10450937 [TBL] [Abstract][Full Text] [Related]
15. Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation. Li L; Leung SSY; Gengenbach T; Yu J; Gao GF; Tang P; Zhou QT; Chan HK Int J Pharm; 2017 Sep; 530(1-2):30-39. PubMed ID: 28709940 [TBL] [Abstract][Full Text] [Related]
16. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization. Jong T; Li J; Morton DA; Zhou QT; Larson I J Pharm Sci; 2016 Mar; 105(3):1156-63. PubMed ID: 26886330 [TBL] [Abstract][Full Text] [Related]
17. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary selectivity and local pharmacokinetics of ambroxol hydrochloride dry powder inhalation in rat. Ren YC; Wang L; He HB; Tang X J Pharm Sci; 2009 May; 98(5):1797-803. PubMed ID: 18837427 [TBL] [Abstract][Full Text] [Related]
19. Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols. Kaewjan K; Srichana T Pharm Dev Technol; 2016; 21(1):68-75. PubMed ID: 25331092 [TBL] [Abstract][Full Text] [Related]
20. Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery. Rattanupatam T; Srichana T Drug Deliv; 2014 Sep; 21(6):397-405. PubMed ID: 24401124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]